These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15805282)

  • 1. Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies.
    Shin I; Edl J; Biswas S; Lin PC; Mernaugh R; Arteaga CL
    Cancer Res; 2005 Apr; 65(7):2815-24. PubMed ID: 15805282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
    Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
    Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.
    Huang TH; Morrison SL
    J Pharmacol Exp Ther; 2006 Mar; 316(3):983-91. PubMed ID: 16291729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.
    Tang HJ; Jin X; Wang S; Yang D; Cao Y; Chen J; Gossett DR; Lin J
    Gynecol Oncol; 2006 Feb; 100(2):308-17. PubMed ID: 16209885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
    Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
    Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
    Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
    Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
    Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
    Barnett SF; Defeo-Jones D; Fu S; Hancock PJ; Haskell KM; Jones RE; Kahana JA; Kral AM; Leander K; Lee LL; Malinowski J; McAvoy EM; Nahas DD; Robinson RG; Huber HE
    Biochem J; 2005 Jan; 385(Pt 2):399-408. PubMed ID: 15456405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice.
    Jetzt A; Howe JA; Horn MT; Maxwell E; Yin Z; Johnson D; Kumar CC
    Cancer Res; 2003 Oct; 63(20):6697-706. PubMed ID: 14583464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro.
    Pierucci D; Cicconi S; Bonini P; Ferrelli F; Pastore D; Matteucci C; Marselli L; Marchetti P; Ris F; Halban P; Oberholzer J; Federici M; Cozzolino F; Lauro R; Borboni P; Marlier LN
    Diabetologia; 2001 Oct; 44(10):1281-95. PubMed ID: 11692177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
    Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
    Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A; Chandrasekher G; Bazan HE
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
    Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
    Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.
    Lindsley CW; Zhao Z; Leister WH; Robinson RG; Barnett SF; Defeo-Jones D; Jones RE; Hartman GD; Huff JR; Huber HE; Duggan ME
    Bioorg Med Chem Lett; 2005 Feb; 15(3):761-4. PubMed ID: 15664853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.
    Xia W; Mullin RJ; Keith BR; Liu LH; Ma H; Rusnak DW; Owens G; Alligood KJ; Spector NL
    Oncogene; 2002 Sep; 21(41):6255-63. PubMed ID: 12214266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells.
    Salinas M; López-Valdaliso R; Martín D; Alvarez A; Cuadrado A
    Mol Cell Neurosci; 2000 Feb; 15(2):156-69. PubMed ID: 10673324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.